Robert J. Mulroy
Oprichter bij Partner Therapeutics, Inc.
Actieve functies van Robert J. Mulroy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Oprichter | - | - |
Loopbaan van Robert J. Mulroy
Eerdere bekende functies van Robert J. Mulroy
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 27-01-2011 | 03-10-2016 |
| Algemeen Directeur | 01-05-1999 | 03-10-2016 | |
| President | 01-05-1999 | 03-10-2016 |
Opleiding van Robert J. Mulroy
| Stanford University | Undergraduate Degree |
| Yale University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Robert J. Mulroy
- Ervaring
